Article
The JAK2 V617F mutation and thrombosis.
British journal of haematology - 1 Nov 2008
Austin S K, Lambert J R
Abstract excerpt
Since the discovery of the JAK2 V617F mutation, the clinical and pathological consequences of this acquired defect have been extensively investigated to determine whether its presence characterises a distinct subgroup of myeloproliferative disorders (MPD). MPD management remains highly dependent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
